1.
Synagis®: Understand the risk of severe RSV disease in a baby
Learn about RSV: the #1 cause of hospitalizations in babies under a year.
2.
Synagis®: Understand the risk of severe RSV disease in a baby
Learn about RSV: the #1 cause of hospitalizations in babies under a year.
3.
Synagis®: Learn why shots are given every 28-30 days during RSV season
Make sure you plan ahead for your baby's first Synagis shot and keep the ... High-risk babies born after the start of RSV season may get their first shot in ...
4.
Synagis®: Learn why shots are given every 28-30 days during RSV season
Your baby's treatment schedule will depend on when the baby was born and when RSV season starts in your area. Remember that the first Synagis shot should be ...
5.
Synagis®: RSV protection medication for high-risk babies' lungs
Synagis® (palivizumab) is the only FDA-approved medication to help protect high-risk babies' lungs from severe RSV. Find out more.
6.
RSV and Synagis® (palivizumab) - Synagis.com
Get detailed information about respiratory syncytial virus (RSV) and the role of Synagis in preventing severe RSV disease in premature infants and other ...
7.
Synagis® (palivizumab) Premature Infants and RSV - Synagis.com
A discussion of the physiological factors in premature infants that increase the risk of severe respiratory syncytial virus (RSV).
8.
Synagis®: Understand the risk of severe RSV disease in a baby
And even as preemies start to look healthy and strong, their lungs remain smaller and less developed than those of full-term babies. That's why preemies are ...
9.
Doctor Discussion Guide
File Format: PDF/Adobe Acrobat - View as HTML Use this Doctor Discussion Guide to help you talk to your healthcare provider. It’s never too early to ask your baby’s doctor about the risk of RSV. ...
10.
07-MED-1301 Synagis Maste#9798D
File Format: PDF/Adobe Acrobat - View as HTML Synagis compared to those who received placebo. INDICATIONS AND USAGE: Synagis is indicated for the prevention of serious lower respiratory tract disease ...
